The potential and action mechanism of polyphenols in the treatment of liver diseases

S Li, HY Tan, N Wang, F Cheung… - … medicine and cellular …, 2018 - Wiley Online Library
Liver disease, involving a wide range of liver pathologies from fatty liver, hepatitis, and
fibrosis to cirrhosis and hepatocellular carcinoma, is a serious health problem worldwide. In …

[HTML][HTML] Inflammaging and cancer: a challenge for the Mediterranean diet

R Ostan, C Lanzarini, E Pini, M Scurti, D Vianello… - nutrients, 2015 - mdpi.com
Aging is considered the major risk factor for cancer, one of the most important mortality
causes in the western world. Inflammaging, a state of chronic, low-level systemic …

[HTML][HTML] Biomarkers of liver cell death

A Eguchi, A Wree, AE Feldstein - Journal of hepatology, 2014 - Elsevier
Hepatocyte cell death during liver injury was classically viewed to occur by either
programmed (apoptosis), or accidental, uncontrolled cell death (necrosis). Growing …

Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms

I Rodriguez-Ramiro, D Vauzour… - Proceedings of the …, 2016 - cambridge.org
Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic component of the
metabolic syndrome and its prevalence is rapidly increasing due to its strong association …

miRNA as molecular target of polyphenols underlying their biological effects

D Milenkovic, B Jude, C Morand - Free Radical Biology and Medicine, 2013 - Elsevier
Polyphenols are the most abundant antioxidants in the human diet and are widespread
constituents of fruits and beverages, such as tea, coffee, and wine. Epidemiological, clinical …

Proanthocyanidins in health and disease

C Bladé, G Aragonès, A Arola‐Arnal, B Muguerza… - Biofactors, 2016 - Wiley Online Library
Proanthocyanidins (PAs) are the most abundant flavonoids in the human diet. Several
epidemiological studies connect PA consumption and health benefits and the designation of …

[HTML][HTML] MicroRNAs as regulators of insulin signaling: research updates and potential therapeutic perspectives in type 2 diabetes

L Nigi, GE Grieco, G Ventriglia, N Brusco… - International journal of …, 2018 - mdpi.com
The insulin signaling pathway is composed of a large number of molecules that positively or
negatively modulate insulin specific signal transduction following its binding to the cognate …

[HTML][HTML] Quercetin Treatment Ameliorates Inflammation and Fibrosis in Mice with Nonalcoholic Steatohepatitis, 3

E Marcolin, B San-Miguel, D Vallejo, J Tieppo… - The Journal of …, 2012 - Elsevier
We investigated whether quercetin protects from steatosis and limits the expression of
proinflammatory and fibrogenic genes in C57BL/6J mice with nonalcoholic steatohepatitis …

Mitochondrial dysfunction: a basic mechanism in inflammation‐related non‐communicable diseases and therapeutic opportunities

A Hernández-Aguilera, A Rull… - Mediators of …, 2013 - Wiley Online Library
Obesity is not necessarily a predisposing factor for disease. It is the handling of fat and/or
excessive energy intake that encompasses the linkage of inflammation, oxidation, and …

[HTML][HTML] The emerging role of microRNAs in NAFLD: highlight of microRNA-29a in modulating oxidative stress, inflammation, and beyond

HY Lin, YL Yang, PW Wang, FS Wang, YH Huang - Cells, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and
ranges from steatosis to steatohepatitis and to liver fibrosis. Lipotoxicity in hepatocytes …